Ceftriaxone Dextrose — Compare Prices at US & Canada Pharmacies

Ceftriaxone-dextrose is the same third-generation cephalosporin as standard ceftriaxone, but supplied as a ready-to-use premixed IV bag — the drug is already dissolved in a dextrose (sugar water) solution at the factory, so nursing staff can hang it directly instead of a pharmacist reconstituting powder and diluting it by hand. Hospitals favor these premix bags for common, predictable doses because they cut a manual compounding step and reduce the chance of a dosing or dilution error. Clinically, it treats the same range of infections as any other ceftriaxone product — community-acquired pneumonia, complicated urinary tract infections, skin and soft-tissue infections, gonorrhea, and empiric coverage for suspected sepsis or meningitis — with the same once-daily dosing that makes ceftriaxone practical for both inpatient and same-day outpatient use.

The dextrose component adds two considerations that don't apply to the plain sodium formulation. First, these bags carry meaningful sugar content, which matters for tight glycemic control in diabetic or critically ill patients and is occasionally noted on ICU flowsheets. Second, dextrose solutions are made using a corn-derived process, so patients with a genuine corn allergy are flagged as a contraindication for this specific formulation — plain ceftriaxone sodium would be used instead.

The core cephalosporin safety issues still apply in full. Ceftriaxone must never be co-administered with IV calcium (including calcium-containing total parenteral nutrition) in neonates, since the combination can form fatal precipitates in the lungs and kidneys; hospitals maintain strict line-flushing protocols around this even in older children and adults. Cross-reactivity with penicillin allergy is possible, and biliary sludging — a reversible, gallstone-like buildup on ultrasound — is a recognized but usually self-resolving side effect of prolonged courses.

Contraindications

CONTRAINDICATIONS Ceftriaxone Injection is contraindicated in patients with known allergy to the cephalosporin class of antibiotics. Solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products. Neonates (≤28 days) Hyperbilirubinemic neonates, especially prematures, should not be treated with Ceftriaxone Injection.

Warnings

WARNINGS Hypersensitivity BEFORE THERAPY WITH CEFTRIAXONE INJECTION IS INSTITUTED, CAREFUL INQUIRY SHOULD BE MADE TO DETERMINE WHETHER THE PATIENT HAS HAD PREVIOUS HYPERSENSITIVITY REACTIONS TO CEPHALOSPORINS, PENICILLINS OR OTHER DRUGS. THIS PRODUCT SHOULD BE GIVEN CAUTIOUSLY TO PENICILLIN-SENSITIVE PATIENTS. ANTIBIOTICS SHOULD BE ADMINISTERED WITH CAUTION TO ANY PATIENT WHO HAS DEMONSTRATED SOME FORM OF ALLERGY, PARTICULARLY TO DRUGS. SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE THE USE OF SUBCUTANEOUS EPINEPHRINE AND OTHER EMERGENCY MEASURES.

Pregnancy & breastfeeding

Pregnancy Teratogenic Effects Reproductive studies have been performed in mice and rats at doses up to 20 times the usual human dose and have no evidence of embryotoxicity, fetotoxicity or teratogenicity. In primates, no embryotoxicity or teratogenicity was demonstrated at a dose approximately 3 times the human dose. There are, however, no adequate and well-controlled studies in pregnant women.